title: When should prophylactic anticoagulation begin after a hip fracture?
authors.affiliation: Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Grant
authors.forename: Amir K
authors.initials: AK
authors.lastname: Jaffer
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D018890:Chemoprevention / Q000592:standards; D006493:Heparin / Q000627:therapeutic use; D006620:Hip Fractures / Q000150:complications*; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D006493:Heparin; D001241:Aspirin